Stay updated on Nivolumab for Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab for Cervical Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedParticipating sites were updated: Bardstown, East Lexington, and Lahey Clinic were added. At the same time, Flaget Memorial Hospital, Saint Joseph Hospital East, and Lahey Hospital and Medical Center were removed, and the document revision was updated to v3.6.3.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the study page and corresponding metadata update.SummaryDifference0.0%

- Check26 days agoChange DetectedCreighton University Medical Center in Omaha, Nebraska was removed; UT MD Anderson Cancer Center was added, and the total number of study locations was updated from 333 to 332.SummaryDifference0.1%

- Check33 days agoChange DetectedThe study page now shows that enrollment has closed ('No longer looking for participants'), and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) are added alongside a revision note for v3.6.0.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page now lists Revision: v3.5.5, replacing Revision: v3.5.4 in the footer. This indicates a minor administrative update to the study record that does not modify core content or outcomes.SummaryDifference0.0%

- Check47 days agoChange DetectedA new site, Saint Joseph Medical Center Hematology and Oncology - Silverdale, was added to the study locations, and Saint Michael Cancer Center was removed from the list of participating sites.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Cervical Cancer Clinical Trial page.